GSTM1 and Schnyder corneal dystrophy: This dual antisickling effect of VZHE-039 is expected to improve its pharmacologic effect in vivo – by targeting both the primary pathophysiology of the disease, Hb polymerization, by two different mechanism, one of which is operative even in the absence of oxygen, which may be quite relevant at low pO2 values in capillaries of SCD patients.